All posts by imreal

EnSoftek’s DrCloudEHR™ – selected to enhance Quality of Care delivery for April May Company


News Image

EnSoftek Inc., the provider of the purpose-built DrCloudEHR™ solution to the Health and Human Services market, is happy to share that, April May Company has selected the DrCloudEHR solution to support behavioral healthcare community needs in Maryland and Washington DC. DrCloudEHR’s highly customizable platform and comprehensive features were key factors in the April May Company selection of DrCloudEHR.

DrCloudEHR is designed to support the healthcare system’s growing focus on data exchange, coordination of care, and elimination of information gaps that could adversely affect positive health outcomes.

“We are excited to partner with April May Company to support their delivery of high-quality, client-centered care to community members in Washington, DC. DrCloudEHR will provide April May Company with a proven EHR solution to help guide children and their families on their journey to better health outcomes,” said Al Lechner, General Manager at EnSoftek.

About April May Company, Inc.

April May Company, Inc. (AMCI) located in Washington, DC, provides a full spectrum of behavioral health care specific to the prevention, health promotion, early intervention, and treatment of individuals suffering from mental health disturbances and intellectual disabilities. They specialize in innovative pediatric evidence-based behavioral health services to support the treatment of developmental, emotional, and behavioral problems of children and families.

About EnSoftek Inc.

EnSoftek empowers health and human services organizations to provide better outcomes for their clients and modernize their business operations with DrCloudEHR. Our industry-leading, cloud-based EHR solution maximizes clinician success, improves engagement, and simplifies work across the entire care continuum, including tracking treatment outcomes. The EnSoftek community includes addiction treatment, mental health, I/DD, long-term care companies, government agencies, and non-profit organizations.

Follow us on Twitter, LinkedIn, and Facebook.

http://www.drcloudehr.com; http://www.ensoftek.com

Share article on social media or email:

The Healthcare Technology Report’s Top 25 Women Leaders in Biotechnology of 2022


The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Biotechnology of 2022. The COVID-19 pandemic saw an explosion in biotech funding in 2020 and 2021. And while that funding has declined somewhat this year, the added attention the industry has received means funding will likely never return to its previous levels. This additional funding and attention has been crucial in the development of countless revolutionary biotechnologies, but none of those technologies would be possible without superb leadership within the companies that created them. The accomplished women selected for this year’s awards represent a diverse range of leadership positions, specialties, and backgrounds, from entrepreneurs building new companies, to scientists discovering innovative ways to treat deadly diseases, to executives enabling their companies to navigate an increasingly competitive industry.

Some of the elite leaders on this year’s list include Ginger Zhou, VP and GM of Genomic Services and Solutions for Azenta Life Sciences, who holds primary responsibility for leading global Genomics business growth, operations, and development of related products and solutions, and oversees more than 1,500 employees and 13 labs in five countries. Meanwhile, Lindsay Jaramillo Steckel, VP of Enterprise Program Management at Tolmar, has been integral in the rapid growth of the company and a catalyst for the extensive and diversified pipeline in multiple therapeutic areas, establishing a team of project and program managers who are responsible for Tolmar’s commercial, product development, operations, and strategic projects. And Sharon Benzeno, Chief Commercial Officer of Immune Medicine at Adaptive Biotechnologies, has led the company’s Drug Discovery group and steered its industry partnerships, including with Genentech, focusing on advancing potential life-saving T-cell based cancer therapies.

The exceptional women on this year’s list were selected based on our comprehensive analysis of hundreds of nominations, taking into consideration professional milestones achieved, demonstrated domain expertise, and longevity in the biotech field. Feedback from colleagues, industry influence, and previous honors and recognition received were also assessed, along with numerous other metrics, to arrive at our final list. Please join us in celebrating The Top 25 Women Leaders in Biotechnology of 2022.

Marianne De Backer (Bayer), Karen Nelson (Thermo Fisher Scientific), Susan Wise (Biogen), Denise Juliano (Premier, Inc.), Tamara Ranalli (Quidel Corporation), Lei Lu (ClinChoice Inc.), Ginger Zhou (GENEWIZ by Azenta Life Sciences), Lindsay Jaramillo Steckel (Tolmar, Inc.), Sharon Benzeno (Adaptive Biotechnologies), Susan Kim (PacBio), Miruna Sasu (COTA, Inc.), Anna Lucsok (Zynex Medical), Elizabeth Kwo (Everly Health), Cindy Dunkle (Denali Therapeutics), Ada Wong (InterVenn Biosciences), Shan Riku (BillionToOne, Inc.), Julie Deane (KCAS Bioanalytical & Biomarker), Melanie Cerullo (Arranta Bio), Hannah Yuan (Mission Bio), Marije Turk (Batavia Biosciences), Amara Siva (Epic Sciences), Diana Rios Ourthiague (Scientist.com), Einav Kraft (Cellares), Connie Bormans (Gene by Gene), Cynthia Voong (Kinnate Biopharma Inc.), Amber Kerby (Pain Specialists of America), Lynette Herscha (Immunitas Therapeutics), Leanne Taylor (Medicure Inc.), Gilly Regev (SaNOtize Research and Development Corporation), Kara Cannon (Enzo Biochem, Inc.), Sonja Krösser (Novaliq GmbH).

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

International Scholarship and Tuition Services, Inc. Presents 2022 Starfish Awards


ISTS Logo

International Scholarship and Tuition Services, Inc. (ISTS) has selected PENCIL and Youth Villages Middle Tennessee as recipients of the 2022 Starfish Campaign awards.

The Starfish Campaign is an annual giving initiative that encourages ISTS employees to demonstrate the company’s Core Value of “Help Others” by nominating and selecting charities to receive a monetary gift as well as volunteer programming participation.

PENCIL is a non-profit organization that builds strategic community partnerships to bridge the resource, training and supply gaps that public schools face that directly impact educational outcomes. Through three primary programs – PENCIL Partners, DG PENCIL Box and Accelerating Scholars Tutors – PENCIL supports more than 81,000 students at 168 Metro Nashville Public Schools.

Youth Villages is a national leader in children’s emotional, mental and behavioral health that offers evidence-based programs – such as in-home services, crisis services, residential treatment and foster care – to help youth and their families live successfully. Youth Villages currently serves children from birth to age 22 with operations in twenty-three states and 101 locations across the country.

Since President & CEO Becky Sharpe established the campaign in 2010, ISTS has provided financial assistance to more than thirty-five organizations. Read more about the Starfish Campaign and view a list of previous recipients at applyISTS.com/about/Community.

###

Founded in 1985, International Scholarship and Tuition Services, Inc. provides comprehensive management of educational assistance programs, including scholarships, grants, loan repayment and tuition reimbursement. ISTS is a 100% women-owned company, focused on offering innovative technology and sustainable solutions to corporations, foundations, associations, unions and other organizations worldwide. For more information about ISTS, visit applyISTS.com.

Share article on social media or email:

Complex DCT Delivery — What is Possible Outside of a Site? Upcoming Webinar Hosted by Xtalks


A DCT is proven to improve patient retention, but if it’s a method of conducting research that the trialist hasn’t experienced before, the benefit, value and possibilities when building decentralized trial visits into a protocol, might not be fully realized.

How do you retain patients in a complex trial? For clinical research professionals, testing medications and procedures on patient populations who feel unwell and have mobility or logistical challenges can be taxing, physically, mentally and emotionally for patients and their families — disruptive to their everyday lives and to the everyday lives of their families. Could incorporating decentralized clinical trial (DCT) visits help?

For many clinical trialists, patient retention and engagement, especially in a complex trial, are challenges that keep them up at night, worrying that valuable patients will not complete the trial. A DCT is proven to improve patient retention, but if it’s a method of conducting research that the trialist hasn’t experienced before, the benefit, value and possibilities when building decentralized trial visits into a protocol, might not be fully realized.

There are many procedures that can be completed in the home, and a significant number of those are far more complex than anticipated. From double blinded healthcare professionals delivering IMP, to timed pharmacokinetic blood draws and digitally linked visits, there are so many complex visit types that can be delivered in a DCT.

Register for this webinar to hear Todd McGrath, Chief Operating Officer, MRN; and Emily McDougal, Executive Director Nurse Management, MRN, talk about how MRN’s decentralized delivery of complex clinical visits benefits clinical trials, sites and patients.

Join the featured speakers for the live webinar on Monday, November 28, 2022, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Complex DCT Delivery — What is Possible Outside of a Site?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Keeping Up with Quality Management in a Business, Upcoming Webinar Hosted by Xtalks


So how to get more people to care about quality management?

Every quality manager wants a connected, collaborative and business-wide culture of quality. But that ambition doesn’t always match reality. Colleagues have their own daily tasks. The board is fixated on financials. And quality’s image of rules and red tape continues to abound. So how to get more people to care about quality management?

This webinar is designed to arm quality professionals with the operational tips and tactics they need to engage their whole business with quality, from top to bottom.

Register for this webinar and learn about strengthening quality management throughout a business.

Join Joshua Tucker, Quality Manager, Cannon Quality Group, for the live webinar on Wednesday, November 30, 2022, at 2pm EST (11am PST).

For more information, or to register for this event, visit Keeping Up with Quality Management in a Business.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

The Top 25 Healthcare Technology Leaders of San Diego for 2022


The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of San Diego for 2022. San Diego often does not receive the same acclaim as other California locales, like San Francisco and Silicon Valley, for its tech industry. However, in 2021, Moove It ranked San Diego number 9 of the 85 best cities for healthtech in the world, when accounting for investment, corporate infrastructure, human capital, and sector expertise. And there is certainly no shortage of innovation coming out of the city, if this list is any indication. In specialties as wide ranging as pharmaceuticals, genomics, microscale robotics, and chemoproteomics, this year’s honorees and the companies they represent are revolutionizing the healthcare technology industry.

Some of the distinguished leaders on this year’s list include Eric Dube, President and CEO of Travere Therapeutics, which is advancing a pipeline of potential first-in-class medicines targeting rare diseases with significant unmet needs and oftentimes no approved treatment options. Meanwhile, Dr. Russell Nofsinger, Senior Director of Business Development of Rady Children’s Institute for Genomic Medicine, has led efforts to expand clinical access to rapid Whole Genome Sequencing (rWGS), developing a network of more than 80 healthcare systems providing access to genomically-informed care for some of their most fragile patients. And since President and CEO Anthony Shimkin took over leadership of AVACEN Medical less than a year ago, the company has launched three new products while moving up the Inc. 5,000 list 761 positions to number 1,480.

The awardees on this year’s list lead from a range of positions, from CEO to CSO, COO, Chief Research Officer, and SVP, but what they have in common is their experienced and effective leadership in the healthcare technology space, advancing products and treatments that are measurably improving the lives of patients around the world. Please join us in celebrating The Top 25 Healthcare Technology Leaders of San Diego for 2022.

Andrew McKnight (Kyowa Kirin), Eric Dube (Travere Therapeutics), Jean-Luc Girardet (Mirum Pharmaceuticals), David Walsey (MEI Pharma), Gregory Richmond (Enumera Molecular), Dr. Russell Nofsinger (Rady Children’s Institute for Genomic Medicine), Ranjan Batra (Locanabio, Inc.), Alex Kiselyov (Bionaut Labs), Pingda Ren (Kumquat Biosciences Inc.), Anthony Shimkin (AVACEN Medical), Robert Wicke (Biolog, Inc.), David Flickinger (NANISX), Christophe Schilling (Genomatica, Inc.), Jeff Hatfield (Vividion Therapeutics, Inc.), Sean Saint (Beta Bionics), Mark McKenna (Prometheus Biosciences, Inc.), Neha Krishnamohan (Kinnate Biopharma Inc.), Preetanshu Pandey (Kinnate Biopharma Inc.), Mary Anderson (Entos), Wendy Taylor (Arcturus Therapeutics), Yisrael Katz (Viracta Therapeutics), Justin Ernst (Belharra Therapeutics), Priyanka Shah (Kinnate Biopharma Inc.), Nichol Miller (Kinnate Biopharma Inc.), Scott Nguyen (Spectrum Pharmaceuticals).

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

Greenberg Traurig’s David J. Dykeman Speaks at ACI Summit on Life Sciences IP Due Diligence


David J. Dykeman, co-chair of global law firm Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Practice and co-managing shareholder of the firm’s Boston office, spoke on a panel titled “Ownership and Inventorship 2.0: Common and Contemporary IP Due Diligence Landmines for the Life Sciences,” Nov. 15 at the American Conference Institute (ACI) 5th Annual Summit on Life Sciences Intellectual Property (IP) Due Diligence.

The panel discussed the implications for life sciences companies employing artificial intelligence (AI) technologies, unique due diligence strategies for life sciences IP assets involving AI, how to determine inventorship and ownership with multiple inventors, assessing the risk of litigation, analyzing the target company’s policies, and who owns data.

A registered patent attorney with 25 years of experience in patent and IP law, Dykeman focuses his practice on securing worldwide IP protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. Dykeman provides strategic patent portfolio development and IP advice for clients, including major research institutions, multinational corporations, and early-stage companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities. An author of over 55 articles and a speaker at over 50 conferences on IP law, Dykeman is the founding co-chair of the American Bar Association’s Medical Devices Committee. In 2022, Dykeman was named “Patent Strategy Attorney of the Year for Massachusetts” by LMG Life Sciences.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to more than 80 attorneys practicing in the areas of bankruptcy and restructuring, corporate, emerging technology, energy, environmental, financial services, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate, and tax. An important contributor to the firm’s international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of helping clients in complex legal matters and hands-on knowledge of the local business community, supported by the firm’s vast network of global resources.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2500 attorneys in 43 locations in the United States, Europe, Latin America, Asia, and the Middle East. The firm reported gross revenue of over $2 Billion for FY 2021 and is consistently among the top firms on the Am Law 100, Am Law Global 100, and NLJ 250. On the debut 2022 Law360 Pulse Leaderboard, it is a Top 15 firm. Greenberg Traurig is Mansfield Rule 5.0 Certified Plus by The Diversity Lab and the Center for Resource Solutions Green-e® Energy program certifies that the firm’s U.S. offices are 100% powered by renewable energy. The firm is often recognized for its focus on philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com.

Share article on social media or email:

New Book Proclaims How to Fix Human Problems (Political, Personal, Economic, Social, or Spiritual) Permanently


“Think of how much better the world would become if people did not rob others, injure others, murder others, or oppress others. If you want the world to be a better place, give love, don’t just receive it only”.

Ever wonder how to fix human problems permanently? To overcome wars, atrocities, hunger, diseases, deaths, sorrows, and other troubles? The solution is the central topic of a new book titled: “Love to Live Forever: Fixing Human Problems Permanently God’s Way”.

The book takes a practical view, with lively illustrations, of how by loving (helping not hurting) people, we can put into practice a divine solution. To overcome our troubles, God wants us to love our neighbors. It is that simple. But not easy, given our “desperately wicked” hearts (see Jeremiah 17:9 in the Holy Bible for this critical diagnosis of the human condition by our Maker). God therefore provides help by putting the Holy Spirit in our hearts to empower, enhance us (see 2 Timothy 1:7, Romans 5:5, and 2 Corinthians 1:21-22).

Believers are also empowered to benefit from a needed spiritual transformation (becoming ‘born again’) enabling access to the kingdom of heaven (see John 3:1-8). Access to God’s kingdom is crucial. It would be the only realm left standing when this world is destroyed and all governments end, and a New Age of world peace emerges.

Providing access into the kingdom of heaven, indeed, God’s ultimate solution for human problems is underscored by love. Specifically, it’s “faith working through love” (see Galatians 5:6, NKJV). That is, having faith in God underscored by a change in how we treat people for the better. It requires an attitude adjustment, and behavior modification in how we conduct our affairs personally, professionally, socially, financially, spiritually, politically, or ideologically.

It requires a renewed mindset with practical action steps focused on helping people. It calls for a mindset that is radically different from the greed-driven, self-centered philosophy that drives much of human conduct today. No wonder we are in such deep troubles, guaranteed to grow worse as disaster looms!

“Think of how much better the world would become if people did not rob others, injure others, murder others, or oppress others,” writes author Fred Igbeare, a former journalist. “If you want the world to be a better place, give love, don’t just receive it only”.

Copies of the book in paperback and eBook (published by TBN’s Trilogy) are available now at you local bookstores. Get your copies online also at Amazon, Barnes & Noble, Google Books, and other outlets. Note that an audio book release is planned, as well as translations into other languages.

Share article on social media or email: